Lexagene Holdings (TSXV:LXG.H) LT-Debt-to-Total-Asset : 0.16 (As of Nov. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lexagene Holdings's long-term debt to total assests ratio for the quarter that ended in Nov. 2022 was 0.16.

Lexagene Holdings's long-term debt to total assets ratio declined from Nov. 2021 (0.17) to Nov. 2022 (0.16). It may suggest that Lexagene Holdings is progressively becoming less dependent on debt to grow their business.

Lexagene Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lexagene Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings LT-Debt-to-Total-Asset Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.27

0.10

0.11

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.17	0.11	0.13	0.16	0.16

Lexagene Holdings LT-Debt-to-Total-Asset Calculation

Lexagene Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Feb. 2022 is calculated as

LT Debt to Total Assets (A: Feb. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Feb. 2022 )	/	Total Assets (A: Feb. 2022 )
	=	1.139	/	10.42
	=	0.11

Lexagene Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2022 is calculated as

LT Debt to Total Assets (Q: Nov. 2022 )	=	Long-Term Debt & Capital Lease Obligation (Q: Nov. 2022 )	/	Total Assets (Q: Nov. 2022 )
	=	0.755	/	4.696
	=	0.16

Lexagene Holdings (TSXV:LXG.H) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lexagene Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (TSXV:LXG.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines